Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-17 Pauls Matthew CHIEF EXECUTIVE OFFICER Purchase +15,000 $1.18 $18K 333,122
2021-05-21 Pauls Matthew CHIEF EXECUTIVE OFFICER Purchase +10,000 $1.63 $16K 318,122
2021-05-19 RAMSAY DAVID A Director Purchase +5,003 $1.58 $8K 866,800
2021-05-18 RAMSAY DAVID A Director Purchase +50,000 $1.62 $81K 861,797
2021-05-17 Chowdhury Badrul A. CHIEF MEDICAL OFFICER Sale −50,000 $1.56 $78K 150,000
2021-05-15 Chowdhury Badrul A. CHIEF MEDICAL OFFICER Exercise or conversion +200,000 200,000
2021-05-15 Chowdhury Badrul A. CHIEF MEDICAL OFFICER Exercise or conversion · Restricted Stock Units −200,000 0
2021-04-19 Pauls Matthew CHIEF EXECUTIVE OFFICER Purchase +27,400 $1.82 $50K 308,122
2021-03-22 Pauls Matthew CHIEF EXECUTIVE OFFICER Purchase +24,100 $2.07 $50K 280,722
2021-03-15 Lowrance David L CHIEF FINANCIAL OFFICER Purchase +13,793 $1.45 $20K 13,793
2021-03-15 McCracken Joseph S Director Purchase +68,965 $1.45 $100K 168,337
2021-03-15 RAMSAY DAVID A Director Purchase +689,655 $1.45 $1000K 811,797
2021-02-22 Pauls Matthew CHIEF EXECUTIVE OFFICER Purchase +28,700 $1.74 $50K 256,622
2020-12-16 Lowrance David L CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +260,000 260,000
2020-12-16 Chowdhury Badrul A. CHIEF MEDICAL OFFICER Grant or award · Stock Option (Right to Buy) +275,000 275,000
2020-12-16 Pauls Matthew CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +500,000 500,000
2020-12-16 McCracken Joseph S Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2020-12-16 RAMSAY DAVID A Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2020-12-16 van Es-Johansson An Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2020-12-16 Hawkins Richard J Director Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 13 of 20 · 390 trades